Theratechnologies has signed another license agreement with Bioartificial Gel Technologies (B.A.G.Tech), extending the license granted in 1999 relating to its extraction process and the applications of its platelet-derived growth factor cocktail. The license agreement announced today covers their in vivo use for therapeutic purposes in the areas of tissue engineering and wound healing. “We are Read more about Theratechnologies Signs Further License Agreement With B.A.G.Tech[…]